Teva’s Board of Directors votes to re-elect Dr. Phillip Frost as Chairman of the Board
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
List view / Grid view
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
30 April 2012 | By Teva Pharmaceutical Industries Ltd
TEVA, has settled patent infringement litigation with Mylan Inc.'s ANDA for Teva’s wakefulness product NUVIGIL® (armodafinil) tablets...
18 April 2012 | By Teva Pharmaceutical Industries Ltd
TEVA announced new data from the Company's expanding CNS portfolio...
5 April 2012 | By Teva Pharmaceutical Industries Ltd
Teva Pharmaceuticals USA, is sole first-to-file for both Orange Book patents listed for Provigil® (modafinil)...
2 April 2012 | By Teva Pharmaceutical Industries Ltd
180-day period of marketing exclusivity awarded...
26 March 2012 | By Teva Pharmaceutical Industries Ltd
New treatment with “dry” mode of delivery seeks to address unmet needs of seasonal and perennial allergy sufferers...
2 March 2012 | By Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd. announced the commercial launch of Progesterone Capsules...
3 January 2012 | By Teva
Study findings published in Frontiers in Bioscience...
1 January 2012 | By Teva
Dr. Jeremy Levin, a former Senior Executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as President and CEO...
30 November 2011 | By Teva
A portion of the profits from Ranbaxy’s sales of Atorvastatin Calcium Tablets during Ranbaxy’s 180-day first-to-file exclusivity period, will be paid to Teva...
15 July 2011 | By Amgen
Amgen announced that the U.S. District Court in Pennsylvania has entered final judgment and a permanent injunction against TEVA...
14 July 2011 | By Cephalon Inc.
Cephalon, Inc. announced that its stockholders voted to approve the TEVA proposal to acquire Cephalon...
2 May 2011 | By Cephalon, Inc.
Teva will acquire all of the outstanding shares of Cephalon for a total enterprise value of approximately $6.8 billion...